Anders Haglund
Impact in
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
- Psychiatry and Mental health top 2%
- Dementia and Cognitive Impairment Research
- Schizophrenia research and treatment
Papers in
-
- Dementia and Cognitive Impairment Research 7
- Schizophrenia research and treatment 2
-
- Cholinesterase and Neurodegenerative Diseases 4
- Treatment of Major Depression 2
- Co-authors
- Bengt Winblad (10 shared papers)A.-L. Wetterholm (7 shared papers)Anders Wimo (8 shared papers)Knut Engedal (6 shared papers)Frans R.J. Verhey (6 shared papers)Hilkka Soininen (4 shared papers)Ponni Subbiah (4 shared papers)Gunhild Waldemar (4 shared papers)
- Journals
- European Neuropsychopharmacology (3 papers)Dementia and Geriatric Cognitive Disorders (3 papers)British Journal of Dermatology (2 papers)Acta Obstetricia Et Gynecologica Scandinavica (2 papers)Alzheimer s & Dementia (1 paper)
- Partner nations
- SwedenFinlandUnited States
In The Last Decade
Anders Haglund
17 papers receiving 1.2k citations
Anders Haglund's Hit Papers
Peers
Comparison fields: 5 of 95
- Geriatrics and Gerontology 191
- Psychiatry and Mental health 673
- Pharmacology 507
- Neurology 170
- Equine 20
Countries citing papers authored by Anders Haglund
This map shows the geographic impact of Anders Haglund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Haglund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Haglund more than expected).
Fields of papers citing papers by Anders Haglund
This network shows the impact of papers produced by Anders Haglund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Haglund. The network helps show where Anders Haglund may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Haglund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD Hit paper breakdown → | 2001 | 578 |
| 2 | 2006 | 281 | |
| 3 | 2006 | 137 | |
| 4 | 2002 | 85 | |
| 5 | 1995 | 29 | |
| 6 | A multicentre (double-blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. | 1997 | 26 |
| 7 | 1991 | 22 | |
| 8 | 1997 | 19 | |
| 9 | 2008 | 15 | |
| 10 | 1985 | 9 | |
| 11 | 2000 | 8 | |
| 12 | 2003 | 7 | |
| 13 | 2011 | 6 | |
| 14 | 2000 | 6 | |
| 15 | 1997 | 2 | |
| 16 | Patient-reported symptoms are still the single most important factor for detecting lymphoma relapse | 2013 | 1 |
| 17 | 2003 | 1 | |
| 18 | 2017 | 0 | |
| 19 | 2020 | 0 |
About Anders Haglund
Anders Haglund is a scholar working on Psychiatry and Mental health, Pharmacology, Epidemiology, Geriatrics and Gerontology and Economics and Econometrics, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (7 papers), Cholinesterase and Neurodegenerative Diseases (4 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers), Nail Diseases and Treatments (3 papers), Pharmaceutical Practices and Patient Outcomes (2 papers), Schizophrenia research and treatment (2 papers), Treatment of Major Depression (2 papers) and Herpesvirus Infections and Treatments (2 papers). The work is most often cited by research in Geriatrics and Gerontology (191 citations), Psychiatry and Mental health (673 citations), Pharmacology (507 citations), Neurology (170 citations) and Equine (20 citations). Anders Haglund has collaborated with scholars based in Sweden, Finland and United States. Frequent co-authors include Bengt Winblad, A.-L. Wetterholm, Anders Wimo, Knut Engedal, Frans R.J. Verhey, Hilkka Soininen, Ponni Subbiah, Gunhild Waldemar, Lena Kilander and Sture Eriksson. Their work appears in journals such as European Neuropsychopharmacology, Dementia and Geriatric Cognitive Disorders, British Journal of Dermatology, Acta Obstetricia Et Gynecologica Scandinavica and Alzheimer s & Dementia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.